Literature DB >> 12401721

Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.

Denis Féliers1, Meredith A Frank, Daniel J Riley.   

Abstract

To determine the role of cell-cycle proteins in regulating pathological renal hypertrophy, diabetes was induced in mice expressing a human retinoblastoma (RB) transgene and in wild-type littermates. Whole-kidney and glomerular hypertrophy caused by hyperglycemia was associated with specific G1 phase cell-cycle events: early and sustained increase in expression of cyclin D1 and activation of cyclin D1-cdk4 complexes, but no change in expression of cyclin E or cdk2 activity. Overexpression of RB alone likewise caused hypertrophy and increased only cyclin D1-cdk4 activity; these effects were not further augmented by high glucose. Identical observations were made when isolated mesangial cells conditionally overexpressing RB from a tetracycline-repressible system hypertrophied in response to high glucose. A mitogenic signal in the same cell-culture system, in contrast, transiently and sequentially activated both cyclin D1-cdk4 and cyclin E-cdk2. In vivo and in cultured mesangial cells, high glucose resulted in persistent partial phosphorylation of RB, an event catalyzed specifically by cyclin D1-cdk4. These data indicate that mesangial hypertrophy caused by hyperglycemia in diabetes results in sustained cyclin D1-cdk4-dependent phosphorylation of RB and maintenance of mesangial cells in the early-to-middle G1 phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401721     DOI: 10.2337/diabetes.51.11.3290

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

Review 1.  Regulation of mRNA translation in renal physiology and disease.

Authors:  Balakuntalam S Kasinath; Denis Feliers; Kavithalakshmi Sataranatarajan; Goutam Ghosh Choudhury; Myung Ja Lee; Meenalakshmi M Mariappan
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17

2.  Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.

Authors:  Weiming Ouyang; Dongyun Zhang; Jingxia Li; Udit N Verma; Max Costa; Chuanshu Huang
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

3.  Transforming growth factor-beta1 regulation of laminin gamma1 and fibronectin expression and survival of mouse mesangial cells.

Authors:  Yan Jiang; Davis W Cheng; Errol D Crook; Lalit P Singh
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

4.  Reduction in maternal circulating ouabain impairs offspring growth and kidney development.

Authors:  Moran Dvela-Levitt; Hagit Cohen-Ben Ami; Haim Rosen; Asher Ornoy; Drorith Hochner-Celnikier; Menachem Granat; David Lichtstein
Journal:  J Am Soc Nephrol       Date:  2014-10-07       Impact factor: 10.121

Review 5.  The heart: mostly postmitotic or mostly premitotic? Myocyte cell cycle, senescence, and quiescence.

Authors:  Sailay Siddiqi; Mark A Sussman
Journal:  Can J Cardiol       Date:  2014-08-23       Impact factor: 5.223

6.  Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.

Authors:  Ravinder Tammali; Ashish Saxena; Satish K Srivastava; Kota V Ramana
Journal:  Endocrinology       Date:  2010-03-22       Impact factor: 4.736

Review 7.  The multiple connections between pRB and cell metabolism.

Authors:  Brandon N Nicolay; Nicholas J Dyson
Journal:  Curr Opin Cell Biol       Date:  2013-08-03       Impact factor: 8.382

Review 8.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

9.  p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin.

Authors:  Zoltan Molnar; Ann B Millward; Wai Tse; Andrew G Demaine
Journal:  Int J Chronic Dis       Date:  2014-03-25

10.  MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3.

Authors:  Xiaomei Mo; Qian Cao; Hui Liang; Jianmin Liu; Huahui Li; Fenghai Liu
Journal:  Mol Med Rep       Date:  2016-01-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.